Search research articles
Contact Us
Filters
Showing results (61-70 of 141) with videos related to
Page
of 15
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 10, 2018
Efficacy and Safety of Second-Line 5-Day Dactinomycin in Case of Methotrexate Failure for Gestational Trophoblastic Neoplasia
Catherine Prouvot, François Golfier, Jérôme Massardier, et al.
British Journal of Clinical Pharmacology
|
September 22, 2022
Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET-dysregulated solid tumours
Xinhui Chen, Nicolas Isambert, Rafael López-López, et al.
American Journal of Obstetrics and Gynecology
|
September 18, 2023
Multiple pregnancy with complete hydatidiform mole and coexisting normal fetus in a retrospective cohort of 141 patients
Touria Hajri, Mona Massoud, Margot Vergne, et al.
Investigational New Drugs
|
May 11, 2010
A dose-escalation phase I trial of nimotuzumab, an antibody against the epidermal growth factor receptor, in patients with advanced solid malignancies
Benoit You, Anthony Brade, Joao M Magalhaes, et al.
Journal of Gynecology Obstetrics and Human Reproduction
|
July 27, 2023
Morbidity, mortality, and prognostic factors in gestational trophoblastic neoplasia with liver metastasis
Delphine Raffin, Pierre Descargues, Touria Hajri, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 16, 2019
Pharmacokinetic Study of Osimertinib in Cancer Patients with Mild or Moderate Hepatic Impairment
Enrique Grande, R Donald Harvey, Benoit You, et al.
Clinical Biochemistry
|
April 29, 2008
Advantages of prostate-specific antigen (PSA) clearance model over simple PSA half-life computation to describe PSA decrease after prostate adenomectomy
Benoit You, Paul Perrin, Gilles Freyer, et al.
Gynecologic Oncology Reports
|
January 22, 2026
Stage I placental site trophoblastic tumor with complete response after pembrolizumab
Pierre Descargues, Lua R Eiriksson, Pascal Rousset, et al.
American Journal of Clinical Oncology
|
March 2, 2011
A Phase II trial of erlotinib as maintenance treatment after gemcitabine plus platinum-based chemotherapy in patients with recurrent and/or metastatic nasopharyngeal carcinoma
Benoit You, Christophe Le Tourneau, Eric X Chen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 30, 2008
Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study
Benoit You, Brigitte Tranchand, Pascal Girard, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 141) with videos related to
Sort By:
Page
of 15
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 10, 2018
Efficacy and Safety of Second-Line 5-Day Dactinomycin in Case of Methotrexate Failure for Gestational Trophoblastic Neoplasia
Catherine Prouvot, François Golfier, Jérôme Massardier, et al.
British Journal of Clinical Pharmacology
|
September 22, 2022
Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET-dysregulated solid tumours
Xinhui Chen, Nicolas Isambert, Rafael López-López, et al.
American Journal of Obstetrics and Gynecology
|
September 18, 2023
Multiple pregnancy with complete hydatidiform mole and coexisting normal fetus in a retrospective cohort of 141 patients
Touria Hajri, Mona Massoud, Margot Vergne, et al.
Investigational New Drugs
|
May 11, 2010
A dose-escalation phase I trial of nimotuzumab, an antibody against the epidermal growth factor receptor, in patients with advanced solid malignancies
Benoit You, Anthony Brade, Joao M Magalhaes, et al.
Journal of Gynecology Obstetrics and Human Reproduction
|
July 27, 2023
Morbidity, mortality, and prognostic factors in gestational trophoblastic neoplasia with liver metastasis
Delphine Raffin, Pierre Descargues, Touria Hajri, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 16, 2019
Pharmacokinetic Study of Osimertinib in Cancer Patients with Mild or Moderate Hepatic Impairment
Enrique Grande, R Donald Harvey, Benoit You, et al.
Clinical Biochemistry
|
April 29, 2008
Advantages of prostate-specific antigen (PSA) clearance model over simple PSA half-life computation to describe PSA decrease after prostate adenomectomy
Benoit You, Paul Perrin, Gilles Freyer, et al.
Gynecologic Oncology Reports
|
January 22, 2026
Stage I placental site trophoblastic tumor with complete response after pembrolizumab
Pierre Descargues, Lua R Eiriksson, Pascal Rousset, et al.
American Journal of Clinical Oncology
|
March 2, 2011
A Phase II trial of erlotinib as maintenance treatment after gemcitabine plus platinum-based chemotherapy in patients with recurrent and/or metastatic nasopharyngeal carcinoma
Benoit You, Christophe Le Tourneau, Eric X Chen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 30, 2008
Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study
Benoit You, Brigitte Tranchand, Pascal Girard, et al.
Page
of 15